CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Volume 16 Issue 1

Novel Drugs: Challenging Entrenched Prescriber/Investment Behaviour is not Just About Education

Behavioural science’s time has come in the pharma industry, as medical communications adapt to a more ambitious and diverse treatment landscape. Drawing on examples ...
Continue Reading →
Volume 16 Issue 1

Biocompatible, Pre-coloured and Sustainable ABS Optimised for Laser-marking to Support Medical UDI Identification along with Sustainability Targets

The EU’s Medical Device Regulation (MDR) and US’ Code of Federal Regulations Title 21, about the labelling of medical devices (21 CFR 801 Subpart B), require a Uniqu...
Continue Reading →
Volume 16 Issue 1

Fighting Counterfeits in the Medical Devices Sector –A Step Beyond the EU MDR

The counterfeiting of health products is a serious and growing concern, and it has come at the forefront of the public mind in recent years with several strict regul...
Continue Reading →
Volume 15 Issue 4

Maintaining Total Compliance and Avoiding Costly Recalls: What Role Does Technology Play?

Like so many sectors, new technologies, software and developments in artificial intelligence (AI) and machine learning (ML), are having a profound impact on the medi...
Continue Reading →
Volume 15 Issue 4

Understanding and Working Towards Container Closure Integrity

Primum non nocere. First, do no harm. This sentence, often considered as the official motto of healthcare providers, organisations, and associations around the wo...
Continue Reading →
Volume 15 Issue 3

Integrated CDMO Partner for Parenteral Drug Products

IPI Speaks with Mr Anil Busimi, VP, Strategy & Marketing of Terumo Medical Care Solutions (TMCS)on the Recent Changes in the CDMO Industry and what the Market is...
Continue Reading →
Volume 15 Issue 3

Taking Healthcare Out of the Hospital: How Device Design Can Empower Users

From point-of-care diagnostics to auto-injectors, medical devices are increasingly enabling more procedures and healthcare activities to be conducted outside of the ...
Continue Reading →
Volume 15 Issue 2

Serving the 0.05% of Patients Living with a Rare Disease

Increasing adoption of digital trials and data-driven commercial strategies has laid the foundations for improved pinpointing of treatments and speedier diagnoses. ...
Continue Reading →
Volume 15 Issue 1

Pharmaceutical Processing Equipment Moves Are Made Easier by Capturing the Power of Air

A proven option to optimize production efficiency is now working its way through the pharma and biotech world: air casters. This technology, similar to air hockey pu...
Continue Reading →
Volume 15 Issue 1

Connected Drug Delivery Device Development: Where Are We At?

The market for parenteral drug-device combination products has evolved rapidly over the last 15–20 years and is expected to grow at a CAGR of 24.3% in the next eight...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026